Skip to main content
Erschienen in: Heart and Vessels 3/2012

01.05.2012 | Original Article

Impact of obesity on plasma B-type natriuretic peptide levels in Japanese community-based subjects

verfasst von: Megumi Koizumi, Hiroyuki Watanabe, Yoshihiro Kaneko, Kenji Iino, Masaru Ishida, Toshimitsu Kosaka, Yutaka Motohashi, Hiroshi Ito

Erschienen in: Heart and Vessels | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The plasma B-type natriuretic peptide (BNP) concentration was recently shown to be inversely correlated with body mass index (BMI). However, very few attempts have been made to associate abdominal obesity and BNP in the Japanese general population. Here, we conducted a cross-sectional study, and examined 339 male and 429 female residents without heart disease in a rural Japanese community who received an annual health checkup in 2006. BNP was inversely associated with both BMI and abdominal circumference (AC) in the age-adjusted regression analysis (p < 0.05). Following adjustment for traditional risk factors, multiple regression analysis revealed that BNP was negatively correlated with AC (p < 0.05), but not BMI. Although metabolic syndrome was not associated with BNP levels, AC had an influence on low BNP levels in the multiple regression analysis using both AC and BMI concurrently (p < 0.05 for AC and p > 0.60 for BMI). These effects were more prominent in men than in women. Collectively, plasma BNP levels are inversely related with obesity, as measured by AC, in Japanese community-based subjects.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Ramos LW, Murad N, Goto E, Antônio EL, Silva JA Jr, Tucci PF, Carvalho AC (2009) Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide. Heart Vessels 24:454–459PubMedCrossRef Ramos LW, Murad N, Goto E, Antônio EL, Silva JA Jr, Tucci PF, Carvalho AC (2009) Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide. Heart Vessels 24:454–459PubMedCrossRef
3.
Zurück zum Zitat Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663PubMedCrossRef Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350:655–663PubMedCrossRef
4.
Zurück zum Zitat Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AHB, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, for the Breathing Not Properly Multinational Study Investigators (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167PubMedCrossRef Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AHB, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA, for the Breathing Not Properly Multinational Study Investigators (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347:161–167PubMedCrossRef
5.
Zurück zum Zitat Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Chon JN, for the Val-HeFT Investigators (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure trial (Val-HeFT). Circulation 107:1278–1283PubMedCrossRef Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Chon JN, for the Val-HeFT Investigators (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure trial (Val-HeFT). Circulation 107:1278–1283PubMedCrossRef
6.
Zurück zum Zitat Koide K, Yoshikawa T, Nagatomo Y, Kohsaka S, Anzai T, Meguro T, Oagawa S (2010) Elevated troponin T on discharge predicts poor outcome of decompensated heart failure. Heart Vessels 25:217–222PubMedCrossRef Koide K, Yoshikawa T, Nagatomo Y, Kohsaka S, Anzai T, Meguro T, Oagawa S (2010) Elevated troponin T on discharge predicts poor outcome of decompensated heart failure. Heart Vessels 25:217–222PubMedCrossRef
7.
Zurück zum Zitat Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PWF, Vasan RS (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594–600PubMedCrossRef Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PWF, Vasan RS (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109:594–600PubMedCrossRef
8.
Zurück zum Zitat Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris RC, Fronhlich ED (2004) Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43:1590–1595PubMedCrossRef Mehra MR, Uber PA, Park MH, Scott RL, Ventura HO, Harris RC, Fronhlich ED (2004) Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43:1590–1595PubMedCrossRef
9.
Zurück zum Zitat Iwanaga Y, Kihara Y, Niizuma S, Noguchi T, Nonogi H, Kita T, Goto Y (2007) BNP in overweight and obese patients with heart failure: an analysis based on the BNP-LV diastolic wall stress relationship. J Cardiac Fail 13:663–667CrossRef Iwanaga Y, Kihara Y, Niizuma S, Noguchi T, Nonogi H, Kita T, Goto Y (2007) BNP in overweight and obese patients with heart failure: an analysis based on the BNP-LV diastolic wall stress relationship. J Cardiac Fail 13:663–667CrossRef
10.
Zurück zum Zitat Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS (2006) B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressure. Am Heart J 152:1071–1076PubMedCrossRef Taylor JA, Christenson RH, Rao K, Jorge M, Gottlieb SS (2006) B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressure. Am Heart J 152:1071–1076PubMedCrossRef
11.
Zurück zum Zitat Tosa S, Watanabe H, Iino K, Terui G, Kosaka T, Hasegawa H, Ito H (2009) Usefulness of plasma BNP levels as a marker of left ventricular wall stress in obese individuals. Int Heart J 50:173–182PubMedCrossRef Tosa S, Watanabe H, Iino K, Terui G, Kosaka T, Hasegawa H, Ito H (2009) Usefulness of plasma BNP levels as a marker of left ventricular wall stress in obese individuals. Int Heart J 50:173–182PubMedCrossRef
12.
Zurück zum Zitat Marinou K, Tousoulis D, Antonopoulos AS, Stefanadi E, Stefanadis C (2009) Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int J Cardiol 138:3–8PubMedCrossRef Marinou K, Tousoulis D, Antonopoulos AS, Stefanadi E, Stefanadis C (2009) Obesity and cardiovascular disease: from pathophysiology to risk stratification. Int J Cardiol 138:3–8PubMedCrossRef
13.
Zurück zum Zitat Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease. J Am Coll Cardiol 53:1925–1932PubMedCrossRef Lavie CJ, Milani RV, Ventura HO (2009) Obesity and cardiovascular disease. J Am Coll Cardiol 53:1925–1932PubMedCrossRef
14.
Zurück zum Zitat Kashihara H, Lee JS, Kawakubo K, Tamura M, Akabayashi A (2009) Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of cardiovascular risk factors. Circ J 73:1881–1886PubMedCrossRef Kashihara H, Lee JS, Kawakubo K, Tamura M, Akabayashi A (2009) Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of cardiovascular risk factors. Circ J 73:1881–1886PubMedCrossRef
15.
Zurück zum Zitat The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity (2002) New criteria for ‘obesity disease’ in Japan. Circ J 66:987–992CrossRef The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity (2002) New criteria for ‘obesity disease’ in Japan. Circ J 66:987–992CrossRef
16.
Zurück zum Zitat Park SH, Choi SJ, Lee KS, Park HY (2009) Waist circumference and waist-to height ratio as predictors of cardiovascular disease risk in Korean adults. Circ J 73:1643–1650PubMedCrossRef Park SH, Choi SJ, Lee KS, Park HY (2009) Waist circumference and waist-to height ratio as predictors of cardiovascular disease risk in Korean adults. Circ J 73:1643–1650PubMedCrossRef
17.
Zurück zum Zitat Dhaliwal SS, Welborn TA (2009) Central obesity and multivariable cardiovascular risk as assessed by Framingham prediction scores. Am J Cardiol 103:1403–1407PubMedCrossRef Dhaliwal SS, Welborn TA (2009) Central obesity and multivariable cardiovascular risk as assessed by Framingham prediction scores. Am J Cardiol 103:1403–1407PubMedCrossRef
18.
Zurück zum Zitat Wada H, Shinjo D, Kameda S, Ono K, Satoh N, Morimoto T, Osakada G, Nakano T, Fujita M, Shimatsu A, Hasegawa K (2010) Transmitral E/A ratio decreases in association with abdominal fat accumulation in patients with impaired glucose tolerance or mild diabetes without left ventricular hypertrophy. Heart Vessels 25:45–50PubMedCrossRef Wada H, Shinjo D, Kameda S, Ono K, Satoh N, Morimoto T, Osakada G, Nakano T, Fujita M, Shimatsu A, Hasegawa K (2010) Transmitral E/A ratio decreases in association with abdominal fat accumulation in patients with impaired glucose tolerance or mild diabetes without left ventricular hypertrophy. Heart Vessels 25:45–50PubMedCrossRef
19.
Zurück zum Zitat Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH Jr, de Lemos JA (2005) Impact of body composition on circulating levels of natriuretic peptides, results from the Dallas Heart Study. Circulation 112:2163–2168PubMedCrossRef Das SR, Drazner MH, Dries DL, Vega GL, Stanek HG, Abdullah SM, Canham RM, Chung AK, Leonard D, Wians FH Jr, de Lemos JA (2005) Impact of body composition on circulating levels of natriuretic peptides, results from the Dallas Heart Study. Circulation 112:2163–2168PubMedCrossRef
20.
Zurück zum Zitat Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS (2007) Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115:1345–1353PubMedCrossRef Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS (2007) Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115:1345–1353PubMedCrossRef
21.
Zurück zum Zitat Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr (2005) Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a proBNP investigation of dyspnea in the emergency department (PRIDE) substudy. Am Heart J 149:744–750PubMedCrossRef Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr (2005) Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a proBNP investigation of dyspnea in the emergency department (PRIDE) substudy. Am Heart J 149:744–750PubMedCrossRef
22.
Zurück zum Zitat Kimura K, Miura S, Iwata A, Sugihara M, Arimura T, Nishikawa H, Kawamura A, Saku K (2009) Association between cardiac function and metabolic factors including adiponectin in patients with acute myocardial infarction. J Cardiol 53:65–71PubMedCrossRef Kimura K, Miura S, Iwata A, Sugihara M, Arimura T, Nishikawa H, Kawamura A, Saku K (2009) Association between cardiac function and metabolic factors including adiponectin in patients with acute myocardial infarction. J Cardiol 53:65–71PubMedCrossRef
23.
Zurück zum Zitat Haugen E, Furukawa Y, Isic A, Fu M (2008) Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. Int J Cardiol 125:216–219PubMedCrossRef Haugen E, Furukawa Y, Isic A, Fu M (2008) Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. Int J Cardiol 125:216–219PubMedCrossRef
24.
Zurück zum Zitat Tamura T, Furukawa Y, Taniguchi R, Sato Y, Ono K, Horiuchi H, Nakagawa Y, Kita T, Kimura T (2007) Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J 71:623–630PubMedCrossRef Tamura T, Furukawa Y, Taniguchi R, Sato Y, Ono K, Horiuchi H, Nakagawa Y, Kita T, Kimura T (2007) Serum adiponectin level as an independent predictor of mortality in patients with congestive heart failure. Circ J 71:623–630PubMedCrossRef
25.
Zurück zum Zitat Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C (2009) Adiponectin: from obesity to cardiovascular disease. Obes Rev 10:269–279PubMedCrossRef Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C (2009) Adiponectin: from obesity to cardiovascular disease. Obes Rev 10:269–279PubMedCrossRef
26.
Zurück zum Zitat Nishikimi T, Maeda N, Matsuoka H (2006) The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69:318–328PubMedCrossRef Nishikimi T, Maeda N, Matsuoka H (2006) The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69:318–328PubMedCrossRef
27.
Zurück zum Zitat Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S (2003) Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52:1274–1278PubMedCrossRef Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S (2003) Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52:1274–1278PubMedCrossRef
28.
Zurück zum Zitat Fox C, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples AC, D’Agostino RB Sr, O’Donnell CJ (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation 116:39–48PubMedCrossRef Fox C, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples AC, D’Agostino RB Sr, O’Donnell CJ (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation 116:39–48PubMedCrossRef
29.
Zurück zum Zitat Maffei S, Del Ry S, Prontera C, Clerico A (2001) Increase in circulating levels of cardiac natriuretic peptide after hormone replacement therapy in postmenopausal women. Clin Sci 101:447–453PubMedCrossRef Maffei S, Del Ry S, Prontera C, Clerico A (2001) Increase in circulating levels of cardiac natriuretic peptide after hormone replacement therapy in postmenopausal women. Clin Sci 101:447–453PubMedCrossRef
30.
Zurück zum Zitat Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, Auchus RJ, de Lemos JA (2007) Associations among androgens, estrogens, and natriuretic peptides in young women. J Am Coll Cardiol 49:109–116PubMedCrossRef Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, Auchus RJ, de Lemos JA (2007) Associations among androgens, estrogens, and natriuretic peptides in young women. J Am Coll Cardiol 49:109–116PubMedCrossRef
31.
Zurück zum Zitat Kanda H, Kita Y, Okamura T, Kadowaki T, Yoshida Y, Nakamura Y, Ueshima H (2005) What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? J Hum Hypertens 19:165–172PubMedCrossRef Kanda H, Kita Y, Okamura T, Kadowaki T, Yoshida Y, Nakamura Y, Ueshima H (2005) What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population? J Hum Hypertens 19:165–172PubMedCrossRef
32.
Zurück zum Zitat Choo R, Chander S, Danjoux C, Morton G, Pearce A, Deboer G, Szumacher E, Loblaw A, Cheung P, Woo T (2005) How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients? Can J Urol 12:2547–2552PubMed Choo R, Chander S, Danjoux C, Morton G, Pearce A, Deboer G, Szumacher E, Loblaw A, Cheung P, Woo T (2005) How are hemoglobin levels affected by androgen deprivation in non-metastatic prostate cancer patients? Can J Urol 12:2547–2552PubMed
33.
Zurück zum Zitat Bartels ED, Nielsen JM, Bisgaard LS, Goetze JP, Nielsen LB (2010) Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. Endocrinology 151:5218–5225PubMedCrossRef Bartels ED, Nielsen JM, Bisgaard LS, Goetze JP, Nielsen LB (2010) Decreased expression of natriuretic peptides associated with lipid accumulation in cardiac ventricle of obese mice. Endocrinology 151:5218–5225PubMedCrossRef
Metadaten
Titel
Impact of obesity on plasma B-type natriuretic peptide levels in Japanese community-based subjects
verfasst von
Megumi Koizumi
Hiroyuki Watanabe
Yoshihiro Kaneko
Kenji Iino
Masaru Ishida
Toshimitsu Kosaka
Yutaka Motohashi
Hiroshi Ito
Publikationsdatum
01.05.2012
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 3/2012
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-011-0143-3

Weitere Artikel der Ausgabe 3/2012

Heart and Vessels 3/2012 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.